![Amy S. Butler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy S. Butler
Corporate Officer/Principal chez The International Union of Basic & Clinical Pharmacology
Profil
Amy S.
Butler is currently a member of The International Union of Basic & Clinical Pharmacology.
Prior to this, she worked as a Laboratory Manager & Senior Scientist at Celentyx Ltd.
Postes actifs de Amy S. Butler
Sociétés | Poste | Début |
---|---|---|
The International Union of Basic & Clinical Pharmacology | Corporate Officer/Principal | - |
Anciens postes connus de Amy S. Butler
Sociétés | Poste | Fin |
---|---|---|
Celentyx Ltd.
![]() Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Celentyx Ltd.
![]() Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Health Technology |
The International Union of Basic & Clinical Pharmacology |